Prellis Biologics, a company developing the tools to create 3D printed organs, announced a $14.5 million Series B round on Wednesday. Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular. Up until this point, Prellis has focused on 3D printing vascular scaffolds that would […]...